Navigation Links
MiMedx Group Announces Record First Quarter Results
Date:5/2/2012

KENNESAW, Ga., May 2, 2012 /PRNewswire/ -- MiMedx Group, Inc.  (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter  ended March 31, 2012.

  • Revenue Increases over 250%
  • Positive Adjusted EBITDA* Achieved for the First Time in Company History
  • Company Achieves Another Reimbursement Milestone for EpiFix®
  • Highlights of First Quarter 2012 ResultsThe Company recorded record revenue for the first quarter of 2012, with revenue of $3.7 million, a 255% or $2.7 million increase over first quarter of 2011 revenue of $1.0 million, and a 41% increase over fourth quarter of 2011 revenue of $2.6 million.  The Company's earnings before interest, taxes, depreciation, amortization and share-based compensation (Adjusted EBITDA*) for the quarter ended March 31, 2012, were a record high of $314,000, a $2.6 million improvement as compared to the Adjusted EBITDA loss of $2.3 million for the first quarter of 2011. The Company also reported record gross margins for the quarter.

    Management Commentary on First Quarter ResultsParker H. "Pete" Petit, Chairman and CEO, stated, "We have worked diligently to achieve positive EBITDA for the first quarter. This is a very important milestone for our shareholders, and we are very pleased that we have passed the threshold into positive EBITDA, which is a signal that we are approaching positive cash flow.  Our first quarter results were driven not only by increased revenue, but also by dramatically improved gross margins and reduced spending in research and development. Our reported gross margins for the first quarter were 74%, more than a twofold improvement over 2011 gross margins of 32%.  Sales in the wound care, spine and orthopedics/sports medicine markets were
    '/>"/>

    SOURCE MiMedx Group, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related biology technology :

    1. MiMedx Group Announces Temporary Trading Symbol Designation
    2. MiMedx Group, Inc. to Present at Noble Financial Sixth Annual Equity Conference
    3. MiMedx Group, Inc. Announces Release Date For Third Quarter Results
    4. MiMedx Group, Inc. to Present at the 13th Annual Needham Growth Conference
    5. MiMedx to Attend American Academy of Orthopedic Surgeons Annual Meeting
    6. MiMedx Announces Launch of AmnioFix™
    7. MiMedx Group, Inc. to Present at the 10th Annual Needham Healthcare Conference
    8. MiMedx Group Announces 2010 Results
    9. MiMedx Group Announces First Quarter 2011 Results
    10. MiMedx Group, Inc. to Present at the Noble Financial Capital Markets Seventh Annual Equity Conference
    11. MiMedx Group Completes $5,000,000 Private Placement
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/19/2014)... PA (PRWEB) December 19, 2014 ... leading developer and manufacturer of needle-free injection technology, ... agreement with Immunomic Therapeutics, Inc. (“ITI”) for ITI ... device with its LAMP™ vaccine platform. , ... an exclusive Worldwide license to the Biojector®-2000 that ...
    (Date:12/19/2014)... Charm Sciences is pleased to announce that its ... M1 in raw commingled milk is the first lateral ... peer reviewed report of the validation by Technology and ... Fisheries Research (ILVO-T&V) has been published by the Taylor ... toxic aflatoxin and a known carcinogen, can be passed ...
    (Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one of the ... Maroulis, Pharm.D. to the newly created position of Vice ... position, Dr. Maroulis will continue to manage the entire ... multi-site pharmacies as the company expands. Dr. Maroulis has ... he has served in many different capacities in the ...
    (Date:12/19/2014)... Dec. 19, 2014 Naurex Inc., a biopharmaceutical ... for diseases of the central nervous system, today announced ... executive officer, will present at the 33 rd ... take place at 3:00 p.m. PST on Tuesday, January ... San Francisco, Calif. ...
    Breaking Biology Technology:Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2
    ... Biotech Inc. (TSX: ONC, NASDAQ: ONCY ) ... U.K. trial of REOLYSIN(R) combined with paclitaxel/carboplatin for patients ... Meeting on Replicating Oncolytic Virus Therapeutics. The meeting is ... 22nd, 2009. The principal investigator for the trial is ...
    ... Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to ... with Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) to ... Lifeline Biotechnologies for a combination of stock, assumption ... originally purchased the products from Lifeline Biotechnologies in ...
    ... Inc. (OTC Bulletin Board: OXBO) today announced the expansion of ... Melville Engle to the board.Engle has over 27 years experience ... money on Wall Street, launched hundreds of products, and has ... Dey LP, where he was the firm,s president and CEO. ...
    Cached Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Head and Neck Results in Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Head and Neck Results in Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial 3Solos Endoscopy, Inc. Sells Ovascope and Mastascope Product Line to Lifeline Biotechnologies, Inc. 2Oxygen Biotherapeutics, Inc. Expands Board of Directors 2
    (Date:12/19/2014)... 18, 2014 Research and Markets ... the "iPhone 5S Fingerprint Sensor - Apple/AuthenTec ... to their offering. ... AuthenTec in July 2012, Apple introduced the fingerprint ... currently the only device of Apple incorporating such ...
    (Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... of the "Micro Market Monitor: North America Perimeter ... http://photos.prnewswire.com/prnh/20130307/600769 The ... at a CAGR of 3.6% from 2014 to 2019. ... this market, Canada is expected ...
    (Date:12/19/2014)... MOUNTAIN VIEW, Calif. , Dec. 18, 2014 /PRNewswire/ ... the publication of a study that pinpoints fine-scale differences ... the United States . Since immigrants ... the United States has served as ... study illuminates how American history and the ongoing mixing ...
    Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 323andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4
    ... have discovered an unusual symbiosis between tiny single-celled algae ... role in marine ecosystems, fertilizing the oceans by taking ... form that other organisms can use. Details ... of Science , emerged from the investigation of ...
    ... Harbor, N.Y. During embryonic development in humans and ... clean of chemical modifications to DNA called epigenetic marks. ... In flowering plants the scenario is dramatically different. ... sometimes not until many years later. When they ...
    ... get plenty of folic acid around the time of conception ... nutrient may one day deserve a spot on the obstetrician,s ... amounts of choline a nutrient found in eggs and ... stress-related illnesses, such as mental health disturbances, and chronic conditions, ...
    Cached Biology News:Unusual symbiosis discovered in marine microorganisms 2Unusual symbiosis discovered in marine microorganisms 3Unusual symbiosis discovered in marine microorganisms 4Scientists uncover mechanism by which plants inherit epigenetic modifications 2Scientists uncover mechanism by which plants inherit epigenetic modifications 3Nutrient in eggs and meat may influence gene expression from infancy to adulthood 2Nutrient in eggs and meat may influence gene expression from infancy to adulthood 3
    ... StabilZyme HRP Conjugate Stabilizer is an aqueous ... and other non-toxic stabilizing chemicals in a ... 6.7. This product contains a ... 20 ppm Proclin 300 (Rohm and Haas ...
    Preparation Note: Prepared by method of Wimmer, E., et al., Biochemistry, 7, 2623 (1968). Quality Clarifier: Acceptor Activity: approx. 1000 picomoles phenylalanine per A 260 unit (not determined b...
    This buffer is Specifically formulated to be used with Endogen's Poly-HRP Streptavidin...
    ... V-106 voice-coil scanning and positioning system ... samples have to be positioned or ... resolution. It provides superior responsiveness compared ... The mechanics (X or XY stage) ...
    Biology Products: